{"title":"Genetic counselling","authors":"P. Elliott, P. Lambiase, Dhavendra Kumar","doi":"10.1093/med/9780198829126.003.0004","DOIUrl":"https://doi.org/10.1093/med/9780198829126.003.0004","url":null,"abstract":"Genetic counselling is one of the major tools in managing inherited cardiac conditions (ICCs) including single gene disorders such as hypertrophic cardiomyopathy and long QT syndrome to multifactorial conditions such as coronary artery disease (CAD) and congenital heart disease (CHD). This chapter deals with genetic counselling for ICCs that are typically transmitted in a Mendelian fashion, for example cardiomyopathies, arrhythmias, Marfan syndrome, as well as inherited lipid disorders. Typically, a genetic counsellor works within a multidisciplinary team including cardiologists, clinical geneticists, nurses, social workers, and psychologists. This chapter covers the role of genetic counsellors, process, consent and confidentiality, communication, and outcomes.","PeriodicalId":302192,"journal":{"name":"Inherited Cardiac Disease","volume":"33 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133971675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Genetic laboratory techniques","authors":"P. Elliott, P. Lambiase, Dhavendra Kumar","doi":"10.1093/MED/9780199559688.003.0030","DOIUrl":"https://doi.org/10.1093/MED/9780199559688.003.0030","url":null,"abstract":"A modern genomic laboratory will offer a range of diagnostic techniques. A biochemical genetic laboratory may also be based in selected centres. In this chapter, a brief account of diagnostic techniques that are useful for inherited cardiac diseases is provided. It covers variant classification and techniques that can detect DNA sequence variants, next generation sequencing, Sanger sequencing, copy number analysis (including whole genome copy number analysis), targeted dosage techniques, and known variant detection. It then gives examples of genetic laboratory reports in the context of investigating potential inherited cardiac diseases, with subsequent familial tests if required.","PeriodicalId":302192,"journal":{"name":"Inherited Cardiac Disease","volume":"33 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114560456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Coronary artery disease and myocardial infarction","authors":"P. Elliott, P. Lambiase, Dhavendra Kumar","doi":"10.1093/med/9780199559688.003.0130","DOIUrl":"https://doi.org/10.1093/med/9780199559688.003.0130","url":null,"abstract":"This chapter covers coronary artery disease (CAD) and myocardial infarction, starting with an introduction to the main causal and treatable risk factors for CAD and myocardial infarction, then goes on to discuss the Mendelian disorders associated with CAD (e.g. Tangier disease, sitosterolaemia, etc.) Association studies based on the candidate gene approach are discussed along with genomic studies, e.g. polygenic risk scores.","PeriodicalId":302192,"journal":{"name":"Inherited Cardiac Disease","volume":"3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122391381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Congenital heart disease","authors":"P. Elliott, P. Lambiase, Dhavendra Kumar","doi":"10.1093/med/9780198829126.003.0005","DOIUrl":"https://doi.org/10.1093/med/9780198829126.003.0005","url":null,"abstract":"This chapter gives an overview of congenital heart disease (CHD), including the genetics that underpins its presentations, general aspects of management, and the genetic consultation in CHD. Individual genetic investigations are outlined (chromosomal microarray and molecular genetics), and then referrals for genetic counselling. The chapter then goes on to outline individual congenital heart diseases, including total anomalous pulmonary venous connection (TAPVC), complete atrioventricular septal defect, tetralogy of Fallot, hypoplastic left heart syndrome, transposition of the great arteries, truncus arteriosus, supravalvar aortic stenosis, coarctation of the aorta, and interruption of the aortic arch. Finally, prenatal diagnosis and management are discussed.","PeriodicalId":302192,"journal":{"name":"Inherited Cardiac Disease","volume":"29 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126067793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Mitochondrial cardiovascular diseases","authors":"P. Elliott, P. Lambiase, Dhavendra Kumar","doi":"10.1093/MED/9780198829126.003.0011","DOIUrl":"https://doi.org/10.1093/MED/9780198829126.003.0011","url":null,"abstract":"This chapter begins by defining the mitochondrial genome, and the subsequent assessment of suspected mitochondrial DNA (mtDNA) disorders. The incidence and prevalence of cardiac involvement in mitochondrial disorders is covered, including the probably under-reporting of this. Different cardiovascular phenotypes associated with mitochondrial disease (arrhythmias, hypertrophic cardiomyopathy, Barth syndrome etc.) are all described, and then the clinical management of the diseases are explained. As there is no fixed treatment, pharmacological regimens to avoid, and other approaches are also included.","PeriodicalId":302192,"journal":{"name":"Inherited Cardiac Disease","volume":"46 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133695665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Cardiomyopathies","authors":"P. Elliott, P. Lambiase, Dhavendra Kumar","doi":"10.1093/med/9780198829126.003.0008","DOIUrl":"https://doi.org/10.1093/med/9780198829126.003.0008","url":null,"abstract":"The chapter covers heart muscle diseases, starting from the classification and the importance of a cardiomyopathy-focused mindset for diagnostic work up. It goes on to examine genetics, diagnosis, common challenging differentials, and family screening in a number of specific cardiomyopathies in both adults and children. Management of specific cardiomyopathies is discussed in detail, including symptomatic and prognostic treatment with drugs, devices, and surgery, with focus on areas of ongoing debate, such as arrhythmic risk stratification and overlap between dilated and arrhythmogenic cardiomyopathy. In the final section it discusses the pathophysiology, diagnosis, and management of a distinct condition (and arguably not a cardiomyopathy), Takotsubo syndrome.","PeriodicalId":302192,"journal":{"name":"Inherited Cardiac Disease","volume":"200 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122148108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Inherited arrhythmias and conduction disorders","authors":"P. Elliott, P. Lambiase, Dhavendra Kumar","doi":"10.1093/MED/9780199559688.003.0104","DOIUrl":"https://doi.org/10.1093/MED/9780199559688.003.0104","url":null,"abstract":"Long QT syndrome is primarily a disorder of repolarization with three principal ion channel currents accounting for the condition. Management revolves around optimization of beta blockade and avoidance of triggers with implantable cardiac defibrillators (ICD) recommended in high risk cases. Brugada syndrome is thought to be caused by Na channel mutations although the aetiology is not fully established. Controversy exists regarding optimal risk stratification approaches. Catecholaminergic polymorphic ventricular tachycardia is caused by abnormalities in calcium handling leading to bidirectional ventricular tachycardia/VF and can be managed using medication –principally beta blockers and occasionally sympathectomy with ICD in cardiac arrest survivors with specific caveats. Inherited conduction disorders should always be considered in patients presenting at a younger age with conduction disease paying specific attention to lamin mutations where an ICD will need to be considered.","PeriodicalId":302192,"journal":{"name":"Inherited Cardiac Disease","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130183317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Perry M. Elliott, Pier D. Lambiase, Dhavendra Kumar
{"title":"Stroke","authors":"Perry M. Elliott, Pier D. Lambiase, Dhavendra Kumar","doi":"10.1093/med/9780198829126.003.0017","DOIUrl":"https://doi.org/10.1093/med/9780198829126.003.0017","url":null,"abstract":"Stroke is the third most common cause of death, and the most common cause of disability in developed countries. This chapter examines the genetics of stroke, and single gene causes (although stroke is often just one component of the phenotype). It then describes Anderson—Fabry disease, CADASIL, RVCL, autosomal-dominant porencephaly and infantile hemiparesis, hereditary cerebral haemorrhage with amyloidosis, Moya-Moya disease, sickle cell disease, and MELAS.","PeriodicalId":302192,"journal":{"name":"Inherited Cardiac Disease","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128669660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Hereditary haemorrhagic telangiectasia","authors":"Kumar Pd, Sasidharan Pk, Ambujakshan Vp","doi":"10.1093/med/9780198829126.003.0015","DOIUrl":"https://doi.org/10.1093/med/9780198829126.003.0015","url":null,"abstract":"The genetics of hereditary haemorrhagic telangiectasia (HHT)—previously known as Rendu–Osler–Weber syndrome—is covered in this chapter, with identified HHT disease-causing genes listed, the clinical features described, and finally treatment options are listed.","PeriodicalId":302192,"journal":{"name":"Inherited Cardiac Disease","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1990-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121693844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}